Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs

Molecular Brain Research

Volumn 50, Issue 1-2, 1997, Pages 136-142

  Riva, M A ^a,b   Tascedda, F ^b   Lovati, E ^b   Racagni, G ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Clozapine; Glutamate; Haloperidol; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR GENE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; HALOPERIDOL; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TIME FACTORS;

ANIMALIA;

EID: 0030664269     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00175-7     Document Type: Article

References (38)

1. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, W.P. Hetrick, S.G. Potkin, C.A. Sandman, W.E. Bunney Jr., E.G. Jones, Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics, J. Neurosci. 16 (1996) 19-30.
2. R.M. Allen, S.J. Young, Phencyclidine induced psychosis, Am. J. Psychiatry 135 (1978) 1081-1084.
3. N.C. Andreasen, J.C. Ehrhardt, V.W. Swayze II, A.J. Alliger, W.T.C. Yuh. G. Cohen, S. Ziebell, Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities, Arch. Gen. Psychol. 47 (1990) 35-44.
4. N.C. Andreasen, H.A. Nasrallah, V. Dunn, S.C. Olson, W.M. Grove, J.C. Ehrhardt, J.A. Coffman, J.H.W. Crossett, Structural abnormalities in the frontal system in schizophrenia. Arch. Gen. Psychol. 43 (1986) 136-144.
5. B. Bogerts, E. Meertz. R. Schonfeld-Bausch. Basal ganglia and limbic system pathology in schizophrenia. Arch. Gen. Psychol. 42 (1985) 784-791.
6. M. Carlsson, A. Carlsson, Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease, Trends Neurosci. 13 (1990) 272-276.
7. D.W. Choi, Glutamate neurotoxicity and diseases of the nervous system, Neuron 1 (1988) 623-634.
8. P. Chomczynski, N. Sacchi, Single step method of RNA isolation by guanidium thiocyanate-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
9. G.L. Collingridge, R.A.J. Lester, Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41 (1989) 143-210.
10. I. Creese, D.R. Burt, S.H. Snyder. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science 192 (1976) 481-483.
11. E.F. Donnelly, D.R. Weinherger, I.N. Waldman, R.J. Wyatt, Cognitive impairment associated with morphological brain abnormalities in computed tomography in chronic schizophrenic patients. J. Nerv. Ment. Dis. 168 (1980) 305-308.
12. M. Dragunow, R. Faull, The use of c-fos as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods 29 (1989) 261-265.
13. A. Fink-Jensen, P. Kristensen, Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain, Neurosci. Lett. 182 (1994) 115-118.
14. L.W. Fitzgerald, A.Y. Deutch, G. Gasic, S.F. Heinemann, E.J. Nestler, Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15 (1995) 2453-2461.
15. P. Follesa, M.K. Ticku. NMDA receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic antagonist exposure, J. Neurosci. 16 (1996) 2172-2178.
16. Hyman, S.E., Nestler, E.J.. The Molecular Foundation of Psychiatry, American Psychiatry Press. Washington DC, 1993.
17. Ilyin. V., Whittermore, ER.. Guastella J., Weber, E. and Woodward, R.M.. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol, Mol. Pharmacol., 50 (1996) 1541-1550.
18. T. Ishii, K. Moriyoshi. H. Sugihara, K. Sakurada, H. Kadotani, M. Yokoi, C. Akazawa. R. Shigemoto, N Mizuno, M. Masu, S. Nakanishi, Molecular characterization of the family of the N-methyl-D-asparlate receptor subunits, J. Biol. Chem. 268 (1993) 2836-2843.
19. D.V. Jeste, J.B. Lohr. Hippocampal pathologic findings in schizophrenia: a morphometric study Arch. Gen. Psychol. 46 (1989) 1019-1024.
20. J.A. Lieberman, A.R. Koreen, Neurochemistry and neuro-endocrinology of schizophrenia: a selective review. Schizophrenia Bull. 19 (1993) 371-429.
21. H. Meguro, H. Mori, K. Araki, E. Kushiya, T. Kutsuwada, M. Yamazaki, T. Kumanishi, M. Arakawa K. Sakimura, M. Mishina, Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs, Nature 357 (1992) 70-74.
22. K.M. Merchant, P.R. Dobner, D.M. Dorsa, Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum, J. Neurosci. 12 (1992) 633-652.
23. H. Monyer, N. Burnashev, D.J. Laune, B. Sakmann, P.H. Seeburg, Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 (1994) 529-540.
24. H. Monyer, R. Sprengel, R. Schoepfer, A. Herb, M. Higuchi, H. Lomeli, N. Burnashev, B. Sakmann, P.H. Seeburg. Heteromeric NMDA receptor: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221.
25. K. Moriyoshi, M. Masu, T. Ishii, R. Shigemoto, N. Mizuno, S. Nakanishi, Molecular cloning and characterization of the rat NMDA receptor, Nature 354 (1991) 31-37.
26. N. Nakanishi, R. Axel, N.A Shneide Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA 89 (1992) 8552-8556.
27. T.V. Nguyen, B. Kasofsky, R. Birnbaum, B. Cohen, S.E. Hyman, Differential expression of c-fos and Zit 268 in rat striatum following haloperidol, clozapine, amphetamine. Proc. Natl. Acad. Sci. USA 89 (1992) 4270-4274.
28. P. O'Donnell, A.A. Grace, Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input, J. Neurosci. 15 (1995) 3622-3639.
29. M.A. Riva, F. Tascedda, R. Molteni, G. Racagni, Regulation of NMDA receptor subunit mRNA expression in the rat brain during postnatal development, Mol. Brain Res. 25 (1994) 209-216.
30. G.S. Robertson, H. Matsumura, H.C Fibiger, Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity, J. Pharmacol. Exp. Ther. 271 (1994) 1058-1066
31. J.B. Sebens, T. Koch, G.J. Ter Horst, J. Korf, Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment, Eur. J. Pharmacol. 273 (1995) 175-182.
32. P.H. Seeburg, The TINS/TiPS lecture; the molecular biology of mammalian glutamate receptor channels, Trends Neurosci. 16 (1993) 359-365.
33. P. Seeman, T. Lee, M. Chau-Wong, K. Wong. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719.
34. D.G. Standaert, C. Testa, G.D. Rudolf, Z.R. Hollingworth, Inhibition of N-methyl-D-aspartate glutamate receptor subuint expression by antisense oligonugletides reveals their role in striatal motor regulation, J. Pharmacol. Exp. Ther. 276 (1996) 342-352.
35. A. Verma, B. Moghaddam. NMDA receptor antagonists impair prefrontal cortex function sas assessed via spatial delayed alternation performance in rats: modulation by dopamine, J. Neurosci 16 (1996) 373-379.
36. D.R. Weinberger, B.K. Lipska, Cortical maldevelopment, anti psychotic drugs, and schizophrenia: a search for common ground. Schizophrenia Res. 16 (1995) 87-110.
37. D.R. Weinberger, K.F. Berman, R. Suddath, E.F. Torrey, Evidence of cysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins, Am. J. Psychol. 149 (1992) 890-897.
38. V. Yoshida, T. Ono, K. Kawano, T. Miyagishi, Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen, Brain Res. 639 (1994) 139-148.